Correlation Between HCW Biologics and Cullinan Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Cullinan Oncology LLC, you can compare the effects of market volatilities on HCW Biologics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Cullinan Oncology.

Diversification Opportunities for HCW Biologics and Cullinan Oncology

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between HCW and Cullinan is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of HCW Biologics i.e., HCW Biologics and Cullinan Oncology go up and down completely randomly.

Pair Corralation between HCW Biologics and Cullinan Oncology

Given the investment horizon of 90 days HCW Biologics is expected to generate 4.66 times more return on investment than Cullinan Oncology. However, HCW Biologics is 4.66 times more volatile than Cullinan Oncology LLC. It trades about 0.03 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.05 per unit of risk. If you would invest  160.00  in HCW Biologics on August 25, 2024 and sell it today you would lose (83.00) from holding HCW Biologics or give up 51.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  Cullinan Oncology LLC

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

HCW Biologics and Cullinan Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Cullinan Oncology

The main advantage of trading using opposite HCW Biologics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.
The idea behind HCW Biologics and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments